New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 21, 2014
08:04 EDTCLSNCelsion formalizing program to develop ThermoDox
Celsion announced that the company is formalizing a program to pursue the development of ThermoDox to investigate applications for treating brain cancer tumors, notably Glioblastoma Multiforme or GBM. In addition to jointly submitting multiple grant applications, the company is also pursuing preclinical studies in collaboration with Costas D. Arvanitis at the Brigham and Women's Hospital and Harvard Medical School.
News For CLSN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CLSN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use